Autolus Therapeutics (AUTL) EBT (2017 - 2025)
Autolus Therapeutics (AUTL) posted quarterly EBT of -$91.5 million for Q4 2025, down 250.04% year-on-year from $61.0 million in Q4 2024, and down 16.45% on a QoQ basis from -$78.6 million in Q3 2025.
Autolus Therapeutics (AUTL) EBT (2017 - 2025) Analysis & Trends
Autolus Therapeutics (AUTL) has reported EBT for 9 consecutive years, with -$91.5 million the latest figure, recorded in Q4 2025.
- Quarterly EBT fell 250.04% year-over-year to -$91.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$285.6 million (down 30.31% YoY) and the FY2025 annual result came in at -$285.6 million, down 30.31% from the prior year.
- EBT eased to -$91.5 million in Q4 2025 per AUTL's latest filing, from -$78.6 million in the prior quarter.
- Over the last five years, EBT for AUTL reached as high as -$7.4 million in Q4 2022 and fell as low as -$91.5 million in Q4 2025.
- A 5-year average of -$49.2 million and a median of -$44.1 million in 2022 frame the typical range for EBT.
- Annual changes were most pronounced in 2022 — EBT soared 69.23% — and 2023, when it slumped 939.1%.
- Year by year, EBT stood at -$24.1 million in 2021, then surged by 69.23% to -$7.4 million in 2022, then sank by 939.1% to -$77.2 million in 2023, then jumped by 66.13% to -$26.1 million in 2024, then slumped by 250.04% to -$91.5 million in 2025.
- According to Business Quant data, EBT over the past three periods registered -$91.5 million, -$78.6 million, and -$47.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Autolus Therapeutics | 404.53 Mn | 103.82 Mn | -1.04 Mn | -91.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -91.52 Mn |
| Sep 30, 2025 | -78.59 Mn |
| Jun 30, 2025 | -47.52 Mn |
| Mar 31, 2025 | -67.94 Mn |
| Dec 31, 2024 | -26.14 Mn |
| Sep 30, 2024 | -82.07 Mn |
| Jun 30, 2024 | -58.22 Mn |
| Mar 31, 2024 | -52.70 Mn |
| Dec 31, 2023 | -77.20 Mn |
| Sep 30, 2023 | -45.87 Mn |
| Jun 30, 2023 | -45.51 Mn |
| Mar 31, 2023 | -39.83 Mn |
| Dec 31, 2022 | -7.43 Mn |
| Sep 30, 2022 | -42.77 Mn |
| Jun 30, 2022 | -42.12 Mn |
| Mar 31, 2022 | -37.09 Mn |
| Dec 31, 2021 | -24.14 Mn |
| Sep 30, 2021 | -39.38 Mn |
| Jun 30, 2021 | -39.53 Mn |
| Mar 31, 2021 | -38.99 Mn |